HB21-1202
Off-label Use Of Approved Drugs To Treat COVID-19
| Type | Bill |
|---|---|
| Session | 2021 Regular Session |
| Subjects |
Concerning the ability of certain health-care providers to repurpose therapeutic drugs that have been approved by the food and drug administration for another purpose to provide treatment to individuals with COVID-19.
Bill Summary:
The bill specifies that:
- A physician, physician assistant, or advanced practice registered nurse with prescriptive authority may prescribe and dispense, and a pharmacist may dispense, therapeutic drugs for off-label use, including hydroxychloroquine sulfate and ivermectin, to provide prophylaxis or outpatient (at-home) and inpatient (hospital) treatment to an individual with COVID-19; and
- This practice is not unprofessional conduct or otherwise grounds for discipline.
(Note: This summary applies to this bill as introduced.)
Prime Sponsors
Representative
Stephanie Luck
Committees
House
Health & Insurance
Related Documents & Information
| Date | Version | Documents |
|---|---|---|
| 03/04/2021 | Introduced |
| Activity | Vote | Documents |
|---|---|---|
| Refer House Bill 21-1202 to the Committee of the Whole. | The motion failed on a vote of 5-8. | Vote summary |
| Postpone House Bill 21-1202 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely. | The motion passed on a vote of 8-5. | Vote summary |
| Date | Location | Action |
|---|---|---|
| 03/31/2021 | House | House Committee on Health & Insurance Postpone Indefinitely |
| 03/04/2021 | House | Introduced In House - Assigned to Health & Insurance |